Peru halts trials of Chinese vaccine over neurological problems in volunteer
The clinical trials of China's Sinopharm COVID-19 vaccine in Peru have been halted after neurological problems were detected in one of its volunteers. The participant presented neurological symptoms that could correspond to a condition called Guillain-Barre syndrome, chief researcher German Malaga said. Peru's clinical trials of the Sinopharm vaccine were due to conclude this week. 